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Abstract
Background: Zinc finger protein A20 (tumor necrosis factor alpha-induced protein 3) functions as a potent
negative feedback inhibitor of the nuclear factor-kB (NF-kB) signaling. It exerts these effects by interrupting the
activation of IkB kinase beta (IKKβ), the most critical kinase in upstream of NF-kB, and thereby controlling
inflammatory homeostasis. We reported previously that electroacupuncture (EA) could effectively suppress IKKβ
activation. However, the mechanism underlying these effects was unclear. Therefore, the current study further
explored the effects of EA on A20 expression in rat brain and investigated the possible mechanism of A20 in
anti-neuroinflammation mediated by EA using transient middle cerebral artery occlusion (MCAO) rats.
Methods: Rats were treated with EA at the “Baihui (GV20),” “Hegu (L14),” and “Taichong (Liv3)” acupoints once a
day starting 2 h after focal cerebral ischemia. The spatiotemporal expression of A20, neurobehavioral scores,
infarction volumes, cytokine levels, glial cell activation, and the NF-kB signaling were assessed at the indicated time
points. A20 gene interference (overexpression and silencing) was used to investigate the role of A20 in mediating
the neuroprotective effects of EA and in regulating the interaction between neuronal and glial cells by suppressing
neuronal NF-kB signaling during cerebral ischemia/reperfusion-induced neuroinflammation.
Results: EA treatment increased A20 expression with an earlier peak and longer lasting upregulation. The
upregulated A20 protein was predominantly located in neurons in the cortical zone of the ischemia/reperfusion.
Furthermore, neuronal A20 cell counts were positively correlated with neurobehavioral scores but negatively
correlated with infarct volume, the accumulation of pro-inflammatory cytokines, and glial cell activation. Moreover,
the effects of EA on improving the neurological outcome and suppressing neuroinflammation in the brain were
reversed by A20 silencing. Finally, A20 silencing also suppressed the ability of EA to inhibit neuronal NF-kB signaling
pathway.
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Conclusions: Ischemia/reperfusion cortical neurons in MCAO rats are the main cell types that express A20, and
there is a correlation between A20 expression and the suppression of neuroinflammation and the resulting
neuroprotective effects. EA upregulated neuronal A20 expression, which played an essential role in the anti-
inflammatory effects of EA by suppressing the neuronal NF-kB signaling pathway in the brains of MCAO rats.
Keywords: Zinc finger protein A20, Cerebral ischemia, Neuroinflammation, Electroacupuncture, NF-kB signaling
pathway
Background
Stroke is one of the leading causes of death and disability
in the USA [1] and China [2], and most cases are caused
by ischemic stroke in the area supplied by the middle
cerebral artery [3]. However, the complex pathological
mechanisms of ischemic/reperfusion injury in ischemic
stroke have hindered the development of clinically effect-
ive treatments. Thus, there is an increasing need to seek
effective intervention targets. In addition to the direct
damage caused by ischemia and hypoxia after middle
cerebral artery occlusion, excitotoxicity, calcium overload,
oxidative stress, apoptosis, autophagy, and neuroinflam-
mation are secondary injury mechanisms. In particular,
induction of neuroinflammation which involves the inter-
action between neurons and glial cells could mobilize the
brain tissue to generate cascade amplification effects of
pathological process by crosstalk of multiple cytokines
and signaling pathways [4]. Nuclear transcription factor
kappa B (NF-kB) controls the initiation and development
of the underlying inflammatory reaction. In the resting
state, the p65/p50 heterodimeric and major form of NF-
kB is mainly held in the cytoplasm bound to NF-kB in-
hibitor protein alpha (IkBα). Shortly after ischemia, the
phosphorylated and activation of IkB kinase beta (IKKβ),
the most critical kinase upstream of NF-kB, results in the
phosphorylation and proteolysis of IkBα, which allows the
p65/p50 dimer to translocate to the nucleus and promote
the expression of pro-inflammatory cytokines (such as
tumor necrosis factor alpha (TNF-α) and interleukin-1
beta (IL-1β). In the early stage of cerebral ischemia/reper-
fusion, this positive feedback cascade amplification loop
occurs in neurons and glial cells that leads to an excessive
inflammatory response in the brain and causes serious
damage [5–12] including breakdown of the blood-brain
barrier and brain edema, which is the main cause of early
death in patients after stroke [13, 14]. Therefore, blocking
the NF-kB signaling pathway is an effective strategy for re-
ducing inflammatory injury after stroke [15].
Zinc finger protein A20 (TNF-α induced protein-3,
TNFAIP3), initially known as TNF-induced and NF-kB
transcription-dependent inflammatory inhibitor, was first
identified in 1990 [16, 17]. Subsequent studies revealed that
A20 functions as both a ubiquitin ligase and a deubiquiti-
nating enzyme [18]. These functions of A20 could interrupt
the phosphorylation of IKKβ activated by TNF-α, IL-1β,
and other multiple upstream inflammatory signals [19–22].
Therefore, A20 is believed to be a key negative feedback in-
hibitor of the NF-kB signaling pathway and a potent en-
dogenous protective factor against the inflammatory
response [23–28] because of its ability to terminate the
amplification of the positive feedback cascade. Previous ani-
mal experiments [29–33] showed that A20 overexpression
could relieve inflammatory injury in the heart, liver, kidney,
and other organs after ischemia/reperfusion. Another study
[34] used DNA microarrays to identify that A20 was one of
the potential anti-inflammation regulators for ischemic
stroke. In addition, some studies [35, 36] have analyzed the
expression of A20 in the brain after focal cerebral ischemia/
reperfusion and assessed its underlying mechanism of ac-
tion for regulating inflammation. However, there have been
conflicting reports regarding the role of A20 in the central
nervous system (CNS) [35, 37–39].
Electroacupuncture (EA) is a complementary combin-
ation therapy consisting of traditional acupuncture and
electrotherapy. It is widely used worldwide, and particu-
larly in China, for treating ischemic stroke and inflam-
matory diseases, and has achieved good results [40–47].
EA is also a candidate therapy recommended by the
World Health Organization (WHO) to treat ischemic
stroke. However, the precise mechanism of action and
functional targets of EA in inflammatory damage after
ischemia/reperfusion remain unclear, even though mul-
tiple studies [46, 48–50] have explored the ability of EA
to regulate inflammatory injury. Our previous study
revealed that EA could inhibit the NF-kB signaling path-
way by suppressing IKKβ activation to reduce cerebral
ischemic injury [51]. However, the specific mechanism
behind these effects is yet to be elucidated.
A20 is a key factor that blocks IKK activation and
inhibits the inflammatory reaction. Therefore, the current
study further explored the effects of EA on A20 expres-
sion in the brain and investigated the possible mechanism
by which EA regulates A20-mediated neuroprotection
using transient middle cerebral artery occlusion (MCAO)
rats. The role of A20 in focal cerebral ischemic/reperfu-
sion-induced neuroinflammation and in regulating the
interaction between neurons and glial cells (astrocytes and
microglia) in neuroinflammation was also investigated.
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Methods
Ethics statement
The experimental protocol used in this study was approved
by the Ethics Committee for Animal Experimentation of
Chongqing Medical University. All procedures were
conducted according to the guidelines of the National
Institutes for Animal Research.
Animals
Specific pathogen-free (SPF) male Sprague-Dawley rats
weighing 280–300 g were purchased from the Experimental
Animal Center of Chongqing Medical University. They
were housed under controlled conditions with 12-h light/
dark cycles, a temperature of 22 ± 2 °C, and 60–70 %
humidity for at least 1 week prior to surgery and treatment.
All the rats were allowed for free access to a standard
rodent diet and tap water.
Lentivirus production and administration
All lentiviruses, including those containing A20 (LV-
A20, 2 × 108 transduction unit, TU/ml) and A20 shRNA
(LV-shA20, 5 × 108 transduction unit, TU/ml) for over-
expressing and knocking down A20, respectively, and
control (LV-ctrl) were purchased from Genechem
(Shanghai, China). The viral dose to be administered
was determined by rendering the 80 % cell infection rate
in brain tissue. Ten days before surgery, the rats received
an intracerebral ventricular injection of 5 μl of LV-A20,
LV-shA20, or LV-ctrl at the calculated dose. The effects
of gene interference on A20 overexpression or silencing
were validated using real-time quantitative polymerase
chain reaction (RT-qPCR) and western blotting.
Intracerebral ventricular injection
The rats were anesthetized by intraperitoneally adminis-
tering 3.5 % chloral hydrate (1 ml/100 g) and prostrated in
a stereotaxic instrument (Stoelting, USA). A midline scalp
incision was made from the overhead to expose the skull
and bregma. According to stereotactic mapping combined
with the rat size, a cranial hole located 1.3 mm lateral and
1.5 mm posterior to the bregma was drilled on the right
hemisphere. A 10-μl Hamilton syringe (Hamilton Co.,
Reno, NV, USA) was slowly placed through the hole into
the right lateral ventricle at a depth of 3.8 mm beneath
the dural surface. Then, the lentivirus or vehicle was in-
fused into the right lateral ventricle at a rate of 0.5 μl/min;
the needle was held in place for an additional 5 min before
withdrawal to prevent reflux.
Focal cerebral ischemia/reperfusion
Focal cerebral ischemia/reperfusion was induced by MCAO
using the intraluminal filament technique described in pre-
vious studies [51, 52]. Briefly, anesthetization was accom-
plished by administering 3.5 % chloral hydrate (1 ml/100 g)
by intraperitoneal injection before surgery. The rats were
fastened on a 37 °C thermostatic table, and the right com-
mon carotid artery and the right external carotid artery
were exposed using a ventral midline neck incision. A 2.0
monofilament nylon suture (Ethicon Nylon Suture; Ethicon
Inc., Osaka, Japan) with its tip rounded by heating was
inserted through an arteriectomy in the external carotid ar-
tery and then advanced into the internal carotid artery
~18–20 mm distal from the carotid bifurcation until mild
resistance indicated occlusion of the origin of the anterior
cerebral artery and the middle cerebral artery. Reperfusion
was accomplished by withdrawing the suture after 2 h of is-
chemia. The incision was then sutured and sterilized. Fur-
thermore, regional cerebral blood flow (rCBF) was
monitored using a disposable microtip fiber optic probe
(diameter 0.5 mm) that was attached to the skull through a
perforation and connected to a laser Doppler computerized
main unit (PeriFlux 5000, Perimed AB, Sweden). The
MCAO was considered adequate if the rCBF showed a
sharp drop to 20 % and recovered to >80 % of baseline
(pre-ischemia) level; the animals that did not meet this re-
quirement were excluded from the analysis.
Body temperature was monitored in all animals. The
rectal temperature was maintained at 38 ± 0.5 °C
throughout the experiment using a rectal thermistor
probe and a thermostatically regulated heating lamp
placed above the body of the animal. The intrastriatal
temperature was monitored and held at 36.5 ± 0.5 °C by
manipulating the height of a small high-intensity lamp
placed above the head during ischemia [53, 54].
Electroacupuncture treatment (EA)
EA treatment was performed as described previously [51].
Briefly, the rats were anesthetized by the intraperitoneal
injection of 3.5 % chloral hydrate (1 ml/100 g). According
to the Experimental Animals Meridians Mapping, the
“Baihui (GV 20),” “Hegu (L14),” and “Taichong (Liv3)”
acupoints, which are located at the intersection of the
sagittal midline and the line between the ears, the radial
side of the left second metacarpal midpoint, and the dent
between the first and second left metatarsal, respectively,
were stimulated at an intensity of 1 mA and a frequency
of 20 Hz for 5 min followed by 2 Hz for 30 min using a
G6805-2 EA Instrument (Model no. 227033; Xinsheng
Ltd., Qingdao, China). The rats were maintained on the
37 °C thermostatic table. EA treatment was given once
daily until the rats were sacrificed; the first treatment
began as the nylon monofilament was withdrawn.
Neurobehavioral evaluation
Neurobehavioral evaluations were performed at the indi-
cated time points (6, 12, 24, 48, and 72 h) by an investi-
gator who was blind to the animal grouping. The 18-
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point system described by Garcia et al. [55] was used
(with modifications) to assess the neurologic deficit.
Infarct volume assessment
The infarct volume was assessed using 2,3,5-triphenyltet-
razolium chloride (TTC, Sigma-Aldrich, USA) staining.
Briefly, the rats were decapitated immediately following
euthanasia 72 h after reperfusion. The brains were rap-
idly harvested and frozen for 10 min at −20 °C. Then,
consecutive 2-mm-thick coronal sections were sliced,
beginning 5 mm from the anterior tip of the frontal lobe,
and stained with 2 % TTC for 10 min at 37 °C. Images
were then captured using a digital camera (Canon IXUS,
Canon Co., Japan) connected to a computer to evaluate
the infarct volume. Unstained areas were defined as
infarct, and the volume was measured using image ana-
lysis software (ImageJ) by an investigator who was un-
aware of the experimental grouping. Infarction volume
was presented as a percentage of the intact hemisphere.
Western blotting
The ischemic/reperfusion area of rat brains supplied by the
right middle cerebral artery was delimited as described pre-
viously [56].,Coronal tissue sections 4-mm-thick were pre-
pared starting 5 mm from the anterior tip of the frontal
lobe, and then homogenized in RIPA lysis buffer (no.
P0013B, Beyotime, Shanghai, China) supplemented with
1 mM phenylmethylsulfonyl fluoride (PMSF, Beyotime,
Shanghai, China) and additional phosphatase inhibitors for
detecting phosphorylated proteins. The total protein was
extracted on ice from supernatants after centrifugation at
12,000 rpm for 10 min. In addition, cytoplasmic/nuclear
proteins were extracted using a Nuclear and Cytoplasmic
Protein Extraction Kit (no. P0027, Beyotime, Shanghai,
China). Western blotting was performed as described previ-
ously [51] using electrophoresis apparatus (Bio-Rad Co.,
USA). Briefly, 50 μg protein in each lane was separated by
SDS-PAGE (Beyotime, Shanghai, China) and transferred to
polyvinylidene fluoride (PVDF) membranes (Millipore Co.,
USA). After blocking with 5 % skim milk/TBST, the mem-
branes were incubated with primary antibodies for 2 h. The
following primary antibodies were used: anti-A20 rabbit
monoclonal (ab92324, Abcam, USA, 1:500 dilution),
anti-IKKβ rabbit monoclonal (ab124957, Abcam, 1:500),
anti-phospho-IKKβ (Ser176/180) rabbit monoclonal
(#2697, Cell Signaling Technology, USA, 1:500), anti-NF-
kB p65 mouse monoclonal (#6956, Cell Signaling
Technology, 1:800), anti-IkBα rabbit polyclonal (18220-1-
AP, Proteintech™ Co., USA, 1:500), and anti-phospho-IkBα
(Ser32) rabbit monoclonal (#2859, Cell Signaling
Technology, 1:500). They were then incubated with the
appropriate secondary horseradish peroxidase-conjugated
goat anti-rabbit (Proteintech™, 1:2000) or goat anti-mouse
antibodies (Proteintech™, 1:2000) for 2 h. Gel imaging
apparatus (Vilber Lourmat fusion FX 7 Spectra, France)
and analysis software (FUSION-CAPT, France) were used
to scan and analyze the blots.
Real-time quantitative polymerase chain reaction (RT-qPCR)
The total RNA was extracted from the same ischemic
reperfusion areas of brain tissue used for western blot-
ting using Trizol reagent according to the manufac-
turer’s instructions (TaKaRa Biotechnology Co, Japan).
cDNA was synthesized using a PrimeScript™ RT reagent
kit with gDNA Eraser (TaKaRa). RT-qPCR was con-
ducted on an iQ5 Gradient Real-Time PCR detection
system (Bio-Rad Co., USA) using SYBR Green (SYBR
Premix Ex Taq™ II, TaKaRa) for fluorescent quantifica-
tion. The following cycling conditions were used: 30 s at
95 °C followed by 40 cycles of 5 s at 95 °C and 30 s at
60 °C. The melting curve of each sample was analyzed
to determine primer-target specificity.
The PCR results were quantified using the threshold
cycle (Ct) method, and the relative mRNA expression of
target genes including tumor necrosis factor alpha-
induced protein 3 (A20), Bcl-2 related protein A1α (A1),
and glial fibrillary acidic protein (GFAP) was normalized
to that of the housekeeping gene β-actin. The nucleotide
sequences of the primers used are shown in Table 1.
Immunofluorescence labeling
Twenty-four hours after reperfusion, the rats were trans-
cardially perfused with saline and 4 % paraformaldehyde
at 4 °C under deep anesthesia. The brain was removed
rapidly, fixed in 4 % paraformaldehyde for 48 h, fully de-
hydration in 30 % sucrose solution, and cut into 10-μm-
thick continuous coronal brain slices beginning 5 mm
from the anterior tip of the frontal lobe. Then, the sec-
tions were processed by permeating the membrane with
0.3 % Triton X-100 for 30 min and performing antigen
retrieval using 0.01 M sodium citrate in the microwave
for 25 min. Nonspecific antigens were then blocked with
5 % goat or donkey serum for 1 h at 37 °C.
Double staining immunofluorescence was used to
determine the cell types in the rat brain that express
A20 and demonstrate NF-kB p65 express in neuron.
The sections were incubated with the following primary
antibodies at 4 °C overnight: anti-NeuN mouse mono-
clonal (to label neurons; MAB377, Millipore Co.,
Germany, 1:100 dilution), anti-GFAP mouse monoclonal
(to label astrocytes; BM0055, Boster, China, 1:100), anti-
Iba-1 goat polyclonal (to label microglia (NB100-1028,
Novus Co., USA, 1:50), anti-A20 rabbit monoclonal
(ab92324, Abcam, 1:100), and anti-NF-kB p65 rabbit
monoclonal (#8242, Cell Signaling Technology, 1:100).
After washing, the sections were incubated with the fol-
lowing fluorescent secondary antibodies for 2 h at 37 °C:
Alexa Fluor 594-conjugated goat anti-rabbit IgG (H+L)
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(SA00006-4, Proteintech, 1:200), Alexa Fluor 488-
conjugated goat anti-mouse IgG (H+L) (SA00006-1,
Proteintech, 1:200), Alexa Fluor 594-conjugated donkey
anti-rabbit IgG (H+L) (SA00006-8, Proteintech, 1:200),
and FITC-conjugated Affinipure donkey anti-goat IgG
(H+L) (SA00003-3, Proteintech, 1:200).
To quantify the immunofluorescence-labeled A20
expression, distinct A20-positive cells were counted in
the ischemic brain tissue and expressed as number per
mm2 (the cell density converted from cell number in
9 × 104 pixels/in.2 of images with ×200 magnification)
based on the method described by Wang et al. [57] with
some modifications. Five view fields in the ischemic
cortex were selected randomly for each sample, and
A20-positive cell counts were performed by an investiga-
tor who was blinded to the experimental groups. All
images were collected using an immunofluorescence
microscope (Axio Observer ZI, Carl Zeiss Micro-
Imaging Co., German) and processed using image pro-
cessing software (Adobe Photoshop CS5, USA).
Immunohistochemistry (IHC)
IHC was performed to show NF-kB p65 nuclear trans-
location at 24 h after reperfusion. Briefly, the rat brains
were fixed, dehydrated, and trimmed as the same
method used in the immunofluorescence assay and em-
bedded in paraffin for slicing into 5-μm-thick sections.
After dewaxing and rehydrating, the sections were
immersed in 0.01 M citrate buffer for antigen retrieval
using the microwave for 25 min. Endogenous peroxides
were blocked by 3 % H2O2 for 10 min and nonspecific
antigens were then blocked with 5 % goat serum for
20 min at 37 °C. The sections were incubated with
primary anti-NF-kB p65 rabbit monoclonal antibody
(#8242, Cell Signaling Technology, 1:200) at 4 °C over-
night, and in sham group, the primary antibody was
replaced with PBS as negative control. The SABC kit (in-
cluding biotinylated goat anti-rabbit secondary antibody
and Strept-Avidin-Biotin Complex; SA1028, BOSTER,
China) and 3,3′-diaminobenzidine tetrahydrochloride
(DAB) peroxidase substrate (AR1022, BOSTER, China)
were used to detect NF-kB p65 immunostain. Images
were scanned and acquired using an OLYMPUS PM20
automatic microscope (Olympus, Tokyo, Japan).
Enzyme-linked immunosorbent assay (ELISA)
The levels of TNF-α and IL-1β in brain homogenates
were determined using ELISA (no. SEA133Ra 96T and
SEA563Ra 96T, Cloud-Clone Corp, USA) following the
manufacturer’s instructions.
Statistical analysis
GraphPad Prism Version 5.0 was used for all statistical ana-
lyses. Neurological scores are presented as median (inter-
quartile ranges) and were analyzed using Kruskal-Wallis
tests followed by post hoc Dunn’s multiple comparison
tests. The rest of the data are expressed as means ± SEMs.
The effect of EA on A20 mRNA or protein levels was com-
pared among groups using two-way ANOVA with Bonfer-
roni post hoc tests. All other data were analyzed using one-
way ANOVA followed by Tukey’s multiple comparison
tests to analyze inter-group differences. Correlations be-
tween A20-positive cell counts and neurologic scores, in-
farct volume, TNF-α and IL-1β content, and the relative
mRNA levels of A1 and GFAP were investigated using
Pearson’s correlation coefficients. P < 0.05 was considered
to indicate statistical significance. All statistical figures were
also generated using GraphPad Prism Version 5.0.
Results
EA upregulates A20 expression following focal cerebral
ischemia-reperfusion
The expression of A20 mRNA and protein in rat ische-
mia/reperfusion brain tissue was quantified using RT-
qPCR and western blotting, respectively, at the indicated
time points (6, 12, 24, 48, and 72 h after reperfusion) in
three groups (MCAO, MCAO + EA, sham; n = 5 per
group for RT-qPCR test and n = 3 per group for western
blotting). Although beginning at 6 h after reperfusion, the
simple ischemia/reperfusion insult induced higher
A20 mRNA transcription than that in the sham
Table 1 List of primers used for real-time PCR
Gene Definition Accession Forward Reverse
A20 Rattus norvegicus tumor
necrosis factor, alpha-induced
protein 3 (Tnfaip3), transcript




A1 Rattus norvegicus BCL2-
related protein A1 (Bcl2a1)
NM_133416.1 5′-AAGCTTCCACAAGAGCAGATTG-3′ 5′-CAGCCAGCCAGATTTAGGTTC-3′
GFAP Rattus norvegicus glial
fibrillary acidic protein (Gfap)
NM_017009.2 5′-AGTGGTATCGGTCCAAGTTTGC-3′ 5′-GTTGGCGGCGATAGTCATTAG-3′
β-actin Rattus norvegicus actin,
beta (Actb),
NM_031144.3 5′-ACGGTCAGGTCATCACTATCG-3′ 5′-GGCATAGAGGTCTTTACGGATG-3′
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group (except at 72 h, all remaining time points P < 0.001;
Fig. 1a), the peak occurred at 24 h after reperfusion and
levels then dropped rapidly to normal comparable with
the sham group at 72 h after reperfusion (P > 0.05; Fig. 1a).
Moreover, A20 mRNA levels were increased significantly
further in the MCAO + EA group compared with the
MCAO group (each time point P < 0.001; Fig. 1a), demon-
strating earlier peak expression at 12 h after reperfusion
and levels still remained high at 72 h after reperfusion.
Similarly, the amount of A20 protein in the ischemic area
was increased significantly in the MCAO + EA group
compared with the MCAO group at each time point (at
12 h P < 0.001, at 24 h P < 0.001, at 48 h P < 0.01, at 72 h
P < 0.01, respectively; Fig. 1b, c). However, levels were only
increased after 12, 24, and 48 h of reperfusion in the
MCAO group compared with the sham group (P < 0.05,
P < 0.001, P < 0.05, respectively; Fig. 1b, c).
The spatial distribution of A20 in the brain tissues
of rats from the three groups (MCAO, MCAO + EA,
and sham; n = 5 per group) was identified using
Fig. 1 Effects of EA on A20 expression in the rat brain after I/R. a A20 mRNA levels in the rat brain were measured at the indicated time points using
RT-qPCR. The graph shows the relative mRNA levels after normalization to the housekeeping gene β-actin. Data are presented as means ± SEM; n = 5
per time point per group. ***P < 0.001 vs. the MCAO group; ###P < 0.001 vs. the sham group. b Western blots showing the expression of A20 in rat
brains at the indicated time points. The housekeeping protein β-actin was used as a loading control. c Graph showing the relative A20 protein levels
after normalized to β-actin. Data are presented as means ± SEM; n = 3 per time point per group. **P < 0.01, ***P < 0.001 vs. the MCAO group; #P < 0.05,
###P < 0.001 vs. the sham group. d Immunofluorescence staining of A20 expression in the ischemia/reperfusion cortex of MCAO and MCAO + EA group
rats 24 h after reperfusion and in the cortex of the sham group rats. Scale bar= 50 μm. e The A20-positive cell counts in the ischemia/reperfusion cortex of
MCAO and MCAO + EA rats and the cortex of rats in the sham group. The A20-positive cell counts were expressed as number/in.2. Data are
presented as means ± SEM; n= 5 per group. ###P< 0.001 vs. the sham group; ***P< 0.001 vs. the MCAO group
Zhan et al. Journal of Neuroinflammation  (2016) 13:258 Page 6 of 18
immunofluorescence staining. There was little A20 ex-
pression in the brains of rats in the sham group (Fig. 1d).
Twenty-four hours after reperfusion the number of A20
immunopositive cells was increased significantly in the
brains of rats in the MCAO group compared with the
sham group (P < 0.001; Fig. 1e). The positive cells were lo-
cated mainly in the focal cerebral ischemia/reperfusion
cortex (Fig. 1e). Moreover, the A20-positive cell count in
the MCAO + EA group was increased significantly
compared with the MCAO group (P < 0.001; Fig. 1d, e).
A20 is expressed mainly in neurons in the focal cerebral
ischemia-reperfusion area
To further determine the main cellular localization of A20
in the rat brain, double immunofluorescence staining was
performed to assess the localization of A20 in neurons, as-
trocytes, and microglia by co-staining for NeuN, GFAP,
and ionized calcium binding adapter molecule 1 (Iba-1),
respectively. Following 2 h of ischemia and 24 h of reper-
fusion, increased levels of A20 protein were found mainly
in the neurons, whereas very little was observed in micro-
glia and astrocytes (Fig. 2). This suggests that neurons play
an important role in the inflammatory response in the
brain after focal ischemia/reperfusion insult since A20 is a
potent inflammatory inhibitor.
A20 exerts neuroprotective effects
To investigate the effects of A20 on cerebral ischemia/re-
perfusion injury, neurobehavioral evaluations were per-
formed and the infarct volume was assessed using an 18-
point neurologic deficit score and TTC staining, respect-
ively. All analyses were performed in four groups (MCAO,
MCAO + LV-A20, MCAO + LV-shA20, and MCAO + ve-
hicle, n = 10 per group) at the indicated time points. Be-
ginning after 6 h of reperfusion following 2 h of ischemia,
there was no clear difference in neurological evaluation
among groups (data not shown). However, 72 h after re-
perfusion, the rats in the MCAO + LV-A20 group exhib-
ited far more notable mitigation of their neurologic
dysfunction compared with those in the MCAO
group (P < 0.05; Fig. 3a). In contrast, that was very lit-
tle improvement in rats in the MCAO + LV-shA20
group compared with the MCAO group (P < 0.05;
Fig. 3a). There was also no significant difference in
Fig. 2 The spatial distribution and cell-type location of A20 in the rat brain after I/R. Brain sections of the ischemia/reperfusion cortex of rats in
the MCAO + EA group 24 h after reperfusion. Sections were stained with double immunofluorescence labeling (a–d), which showed the
upregulated expression of A20 protein (red) in neurons (green, identified using NeuN). e–h Very few of A20-positive (red) astrocytes (green,
identified using GFAP) were observed. i–l A20 (red) was barely presented in microglial cells (green, identified using iba-I). Scale bar = 50 μm. 1–3
were the magnified parts from the merged images of d, h, l which more clearly showed the location relationship between A20 and neurons,
astrocytes, and microglia, respectively. Scale bar = 25 μm
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neurologic score between the MCAO and MCAO +
vehicle groups (P > 0.05; Fig. 3a).
Consistent with this, rats in the MCAO + LV-A20
group exhibited smaller brain infarct volumes compared
with those in the MCAO group 72 h after reperfusion
(P < 0.001, Fig. 3b, c). In addition, the infarct volume was
larger in the MCAO + LV-shA20 group than the MCAO
group (P < 0.001; Fig. 3b, c). The mean infarct volume
was similar in the MCAO + vehicle and MCAO groups
(P > 0.05; Fig. 3b, c). Therefore, these data suggest that
the stroke outcome could be improved by the overex-
pression of A20 but exacerbated by A20 deficiency.
A20 silencing largely prevents the neuroprotective effects
of EA
Next, studies were performed to investigate whether the
increased levels of A20 were essential for the therapeutic
effects of EA on post-ischemia injury. The effects of A20
silencing on EA-induced neuroprotection were also
assessed by performing neurobehavioral evaluations and
measuring infarct volume in four groups (MCAO,
MCAO + EA, MCAO + EA + LV-shA20, MCAO + EA
+ vehicle, n = 10 per group) 72 h after reperfusion.
Compared with the MCAO group, the neurologic
function of rats in the MCAO + EA group was improved
(P < 0.05; Fig. 4a) and the infarct volume was signifi-
cantly smaller (P < 0.001; Fig. 4b, c). In contrast, the con-
ditions were worsened in the rats in the MCAO + EA +
LV-shA20 group, as evidenced by a poor neurologic def-
icit and larger infarction volume compared with the
MCAO + EA group (P < 0.05, P < 0.001, respectively;
Fig. 4a–c). Finally, the neurologic scores and infarct vol-
ume were similar in the MCAO + EA + vehicle and
MCAO + EA groups (P > 0.05; Fig. 4a–c).
A20 silencing inhibits the anti-inflammatory effects of EA
The effects of A20 silencing on the anti-inflammatory
effects of EA were investigated in five groups
(MCAO, MCAO + EA, MCAO + EA + LV-shA20,
MCAO + EA + vehicle, sham, n = 5 per group) 24 h
after cerebral ischemia/reperfusion.
Because the cytokines, TNF-α and IL-1β are the most
important pro-inflammatory mediators after the onset of
ischemia [58]. The levels of both cytokines were mea-
sured using ELISA to determine the scale of the inflam-
matory response in rat brain tissue. TNF-α and IL-1β
levels in focal ischemia/reperfusion brain tissue were
Fig. 3 Neuroprotective effects of A20 on focal cerebral ischemia reperfusion injury. The neurological score and brain infarction volume were evaluated
72 h after reperfusion in rats in the four groups (MCAO, MCAO + LV-A20, MCAO + LV-shA20, and MCAO + vehicle). a Neurological scores are presented
as median (interquartile range), n = 10 per group. *P < 0.05, #P < 0.05 vs. the MCAO group. b Brain infarct volume presented as a percentage of the
intact hemisphere. Data are presented as means ± SEM, n = 10 per group. ***P < 0.001, ###P < 0.001 vs. the MCAO group. c Images of cerebral infarction
(white, infarct tissue; red, non-infarct tissue) were stained using 2,3,5-triphenyltetrazolium chloride in coronal sections of rat brains
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increased significantly in the MCAO group compared
with the sham group (P < 0.001, P < 0.001, respectively;
Fig. 5a, b) but were decreased significantly in the MCAO
+ EA group compared with the MCAO group (P < 0.05,
P < 0.001, respectively; Fig. 5a, b). Moreover, an anti-
inflammatory effects of EA were reduced significantly by
silencing A20 mRNA in the MCAO + EA + LV-shA20
group, since the brains exhibited higher TNF-α and
IL-1β levels than those in the MCAO + EA group
(P < 0.001, P < 0.001, respectively; Fig. 5a, b). There
was no difference in TNF-α and IL-1β levels be-
tween the MCAO + EA and MCAO + EA + vehicle
groups (P > 0.05, P > 0.05, respectively; Fig. 5a, b).
Innate immunocytes such as microglial [59] and
astrocyte [60] play an essential role in the early stage
of the inflammatory response after cerebral ischemia/
reperfusion [61, 62]. Therefore, the activation of these
innate immunocytes was detected by using RT-qPCR
to measure the mRNA levels of A1 and GFAP, which
are markers of microglia and astrocyte [37] activation,
respectively. Twenty-four hours after reperfusion, the
relative levels of A1 and GFAP were clearly elevated
in the MCAO group compared with the sham group
(P < 0.001, P < 0.001, respectively; Fig. 5c, d). However,
levels were significantly lower in the MCAO + EA group
compared with the MCAO group (P < 0.001, P < 0.05, re-
spectively; Fig. 5c, d). Furthermore, compared with the
MCAO + EA group, the relative levels of A1 and GFAP
were significantly higher in the MCAO + EA + LV-shA20
group (P < 0.001, P < 0.001, respectively; Fig. 5c, d). There
was no difference between the MCAO + EA and
MCAO + EA + vehicle groups (P > 0.05, P > 0.05,
respectively; Fig. 5c, d).
The activation state of glial cells was investigated further
by using immunofluorescence staining to assess morpho-
logical changes. Glial cell activation patterns appeared in
the ischemia/reperfusion cortex of rats. Activated astrocytes
show increased GFAP immunoreactivity and thickening of
the cytoplasmic processes [63] (Fig. 5e). Activated microglia
present with enlarged and brightened cell bodies together
with shortened and thickened processes [64] (Fig. 5f). Glial
cells in the brains of rats in the sham group were in the
resting state, with a ramified morphology and delicate pro-
cesses. Glial cell activation was the most extensive and evi-
dent in the cerebral ischemia/reperfusion area of the
MCAO + EA + LV-shA20 group; however, it was inhibited
Fig. 4 A20 silencing inhibits the neuroprotective effects of EA on focal cerebral ischemia reperfusion injury. Neurological score and brain infarction volume
were evaluated 72 h after reperfusion in rats in the four groups (MCAO, MCAO + EA, MCAO + EA + LV-shA20, MCAO + EA + vehicle). a Neurological scores
are presented as median (interquartile range), n= 10 per group. *P< 0.05 vs. the MCAO group; ###P< 0.001 vs. the MCAO + EA group. b Brain infarction
volume presented as a percentage of the intact hemisphere. Data are presented as means ± SEM, n = 10 per group. ***P < 0.001 vs. the MCAO
group; ###P < 0.001 vs. the MCAO + EA group. c Images of cerebral infarction (white, infarct tissue; red, non-infarct tissue) were stained
using 2,3,5-triphenyltetrazolium chloride in coronal sections of rat brains
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by EA in the brains of rats in the MCAO + EA group. An
intermediate phenotype was observed in the MCAO group
(Fig. 5e, f). The morphological changes in the glial cells
were consistent with the expression of GFAP and A1
mRNA observed in the same groups.
Correlation between neuronal A20 expression and
neurologic outcome and inflammatory response after
cerebral ischemia reperfusion
Next, the role of neuronal A20 expression in restraining the in-
flammatory response and attenuating neurologic dysfunction at
Fig. 5 A20 silencing prevents the anti-inflammatory effects of EA after focal cerebral ischemia reperfusion. Experiments were performed 24 h after
reperfusion in the ischemia/reperfusion cortex, n = 5 per group. a TNF-α and b IL-1β content was measured using ELISA. $$$P < 0.001 vs. the sham
group; *P < 0.05, ***P < 0.001 vs. the MCAO group; ###P < 0.001 vs. the MCAO + EA group. The relative mRNA levels of c A1 and d GFAP were mea-
sured using RT-qPCR. $$$P < 0.001 vs. the sham group; ***P < 0.001, *P < 0.05 vs. the MCAO group; ###P < 0.001 vs. the MCAO + EA group. The acti-
vated morphology of astrocytes and microglia was demonstrated using e GFAP and f Iba-1 immunofluorescence staining (green), respectively.
Yellow arrows indicate reactive astrocytes with thick cell bodies, and red arrows indicate hypertrophied activated microglia, noted by their stout,
dense appearance with shorter and thicker branched projections. Scale bar = 50 μm
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the early stage of focal cerebral ischemia/reperfusion was investi-
gated further. Neuronal A20-positive cells were counted in the
focal cerebral ischemia/reperfusion area of rats in the four
groups (MCAO, MCAO + EA, MCAO + EA + LV-shA20,
MCAO + EA + vehicle, n=5 per group). The results of neur-
onal A20-positive cell counts were paired randomly with those
results in the correspondent groups from the above two A20-
silencing experiments. Then, the correlation between neuronal
A20-positive cell counts and neurologic scores, infarct volume,
TNF-α and IL-1β content, and relative A1 and GFAP mRNA
levels was investigated, respectively (n=20 pair, respectively), ac-
cording to the method described byWang et al. [65].
There was a clear positive correlation between neur-
onal A20-positive cell counts and neurologic scores
(r = 0.8140, P < 0.0001; Fig. 6a), and a significant
negative correlation between neuronal A20-positive cell
counts and infarct volume (r = −0.7591, P < 0.0001;
Fig. 6b), TNF-α content (r = −0.8504, P < 0.0001; Fig. 6c),
IL-1β content (r = −0.8362, P < 0.0001; Fig. 6d), relative A1
mRNA levels (r = −0.8704, P < 0.0001; Fig. 6e), and relative
GFAP mRNA levels (r = −0.8209, P < 0.0001, Fig. 6f).
The upregulation of A20 is required for EA to inhibit
neuronal NF-kB signaling
Next, we determined whether the increased neuronal
A20 expression was essential for the therapeutic effects
of EA on the post-ischemia inflammatory injury by inhi-
biting the NF-kB signal pathway. As shown in Fig. 7a, b,
the rats were randomized into four groups (MCAO,
MCAO + EA, MCAO + EA + LV-shA20, MCAO + EA +
Fig. 6 The correlations between A20-positive neuronal cell count and the inflammatory response and neurological outcome. a The relationship between
the number of A20-positive neurons and neurological scores (n= 20 pairs, r= 0.8140, P< 0.0001). b The relationship between the number of A20-positive
neurons and the relative infarct volume (n= 20 pairs, r=−0.7591, P< 0.0001). c The relationship between the number of A20-positive neurons and TNF-α
content (n= 20 pairs, r=−0.8504, P< 0.0001). d The relationship between the number of A20-positive neurons and IL-1β content (n= 20 pairs, r=−0.8362,
P< 0.0001). e The relationship between the number of A20-positive neurons and the relative A1 mRNA level (n= 20 pairs, r=−0.8704, P< 0.0001). f The
relationship between the number of A20-positive neurons and the relative GFAP mRNA level (n= 20 pairs, r=−0.8209, P< 0.0001)
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Fig. 7 (See legend on next page.)
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vehicle, n = 5 per group). Western blotting was used to
measure A20, p-IKKβ, IKKβ, p-IkBα, IkBα, nuclear p65,
and cytoplasmic p65 proteins in the focal ischemia/reper-
fusion area 24 h after reperfusion. The p-IKKβ/IKKβ and
p-IkBα/IkBα, respectively, represent the phosphorylation
ratio of IKKβ and IkBα, and nucleus-p65/cytoplasm-p65
represents the nuclear translocation ratio of NF-kB p65.
All these ratios were used to comparatively assess the
activity of the NF-kB signaling pathway between individ-
ual groups.
Twenty-four hours after reperfusion, there were in-
creased A20 protein levels, a reduced phosphorylation
ratio of IKKβ and IkBα, and suppressed nuclear trans-
location of NF-kB p65 in the MCAO + EA group com-
pared with the MCAO group (P < 0.05, P < 0.05, P <
0.001, P < 0.01, respectively; Fig. 7b). In contrast, little
A20 protein expression was detected in the MCAO +
EA + LV-shA20 group, which also exhibited significantly
elevated phosphorylation ratios of IKKβ and IkBα and
the increased nuclear translocation of NF-kB p65 com-
pared with the MCAO + EA group (P < 0.001, P < 0.001,
P < 0.001, P < 0.001, respectively; Fig. 7b). These results
suggest that neuronal A20 expression is an essential for
the ability of EA to inhibit NF-kB signaling.
Immunohistochemistry was also performed to show
NF-kB p65 nuclear translocation at 24 h after reperfu-
sion. The rats were randomized into four groups (sham,
MCAO, MCAO + EA, MCAO + EA + LV-shA20, n = 5
per group). As shown in Fig. 7c, immunostaining for
NF-kB p65 was much stronger both in the cytoplasm
and nucleus of large part of cells in the ischemia/reper-
fusion cortex of MCAO rats (Fig. 7c2), as compared to
the faint staining observed in sham group (Fig. 7c1). Al-
though MCAO + EA rats were also shown substantial of
NF-kB p65 staining, most of which were restrained in
the cytoplasm (Fig. 7c3). Nevertheless, significant NF-kB
p65 staining was predominantly detected throughout
those cells with shrank body in MCAO + EA + LV-
shA20 group (Fig. 7c4). These results were in line with
the Western blotting analysis above with the morpho-
logical characteristics of NF-kB p65 nuclear transloca-
tion. However, the morphological characteristics of
specific cell type of NF-kB p65 nuclear translocation
needed to be furthered.
Since A20 expression was mainly regulated in neurons
by EA, its effect on neuronal NF-kB signaling and corre-
sponding morphological changes of neurons were
thereby exhibited by double immunofluorescence stain-
ing. The Rats were randomized into four groups (sham,
MCAO, MCAO + EA, MCAO + EA + LV-shA20, n = 5
per group). Similar to immunohistochemistry results,
only a small amount of NF-kB p65 were detected in the
cytoplasm of individual neuron in the sham rat brains
(Fig. 7d1–4) whereas, at reperfusion 24 h, sorts of brain
cells had expressed NF-kB p65 in the ischemia/ reperfu-
sion cortex of MCAO rats. Especially, a large number of
neurons not only had significant NF-kB p65 immuno-
fluorescence in the cytoplasm but also shown the posi-
tive staining in the nucleus, suggesting nuclear
translocation. Moreover, these neurons arranged loosely
and disconnectedly, with partial cell body representing
swollen (Fig. 7d5–8). Contrarily, EA group has shown
neuron arrangement basically kept closely and orderly in
the ischemia/reperfusion cortex, and despite neuronal
NF-kB p65 expression was also abundant, most of them
were confined to the cytoplasm (Fig. 7d9–12). However,
A20 silencing seriously damaged EA blocking NF-kB
p65 nuclear translocation. The dense NF-kB p65 im-
munofluorescence staining was detected covering
throughout cytoplasm and nucleus of nearly all neurons
in the ischemia/reperfusion cortex of MCAO + EA +
LV-shA20 rats. Accordingly, cell number in this area was
decreased significantly, and the residual neurons ar-
ranged sparsely, with a shrank body and broken nucleus
(Fig. 7d13–16). Technically, maybe the immunofluores-
cence was inferior to immunohistochemistry in demon-
stration effect of NF-kB p65 nuclear translocation, but it
could better reveal the relationship between specific
neuronal NF-kB signaling and corresponding morpho-
logical changes of neurons after ischemia/reperfusion in-
jury. Thus, these results precisely indicated that A20 was
involved in EA regulating neuronal NF-kB signaling and
also effectively influenced the neuronal morphological
characteristics, which could affect the neuron survival.
(See figure on previous page.)
Fig. 7 EA suppressed NF-kB signaling by upregulating A20. a Western blots showing the expression of A20, p-IKKβ, IKKβ, p-IkBα, IkBα, nuclear p65, and
cytoplasmic p65 in ischemia/reperfusion cortical extracts 24 h after reperfusion. β-actin was used as the loading controls for total and cytoplasm
proteins, and lamin B was used as the nuclear loading control. b The phosphorylation ratio of IKKβ and IkBα is presented as the p-IKKβ/IKKβ and
p-IkBα/IkBα ratios, respectively. The nuclear translocation ratio of NF-kB p65 was indicated as nucleus-p65/cytoplasm-p65. n = 5 per group. *P < 0.05,
**P < 0.01, ***P < 0.001 vs. the MCAO group; ###P < 0.001 vs. the MCAO + EA group. c At 24 h after reperfusion, NF-kB p65 immunohistochemistry
(brown) was performed to show NF-kB p65 nuclear translocation in the ischemia/reperfusion cortex of rats from the four groups (sham, MCAO, MCAO
+ EA, MCAO + EA + LV-shA20, n = 5 per group). Yellow arrows indicate NF-kB p65 mainly in cytoplasm, and red arrows indicate NF-kB p65 both in
cytoplasm and nucleus. Scale bar = 50 μm. d Immunofluorescence staining was performed to demonstrate NF-kB p65 expression (red) in neurons
(green) of ischemia/reperfusion cortex of rats from the four groups (sham, MCAO, MCAO + EA, MCAO + EA + LV-shA20, n = 5 per group) at reperfusion
24 h. Yellow arrows indicate NF-kB p65 mainly in cytoplasm, and red arrows indicate NF-kB p65 both in cytoplasm and nucleus. Scale bar = 50 μm
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Discussion
The inflammatory response induced by focal cerebral is-
chemia/reperfusion is a “double-edged sword” to the CNS,
and the early excessive inflammatory response is a very
important cause of secondary neuronal injury [66–74]. In
this study, we established a rat model of focal cerebral is-
chemia/reperfusion and found that activated astrocytes
and microglia act as inflammatory cells in brain tissue and
that the accumulation of pro-inflammatory cytokines such
as TNF-α and IL-1β contribute to the formation of cere-
bral infarction, deteriorated neurological function, and the
induction of inflammatory brain damage. During this
process, NF-kB signaling regulates the initiation and de-
velopment of inflammation and activates a positive feed-
back that has an amplification effect. A20 is a key negative
feedback inhibitor of the NF-kB signaling pathway. It reg-
ulates the dynamic balance of the inflammatory response
and particularly prevents an excessive inflammatory re-
sponse, chronic inflammation, and autoimmune diseases
[24]. However, studies regarding the specific role of A20
in the regulation of the acute inflammatory responses in-
duced by cerebral ischemia/reperfusion are in their in-
fancy. Therefore, the current study explored the
characteristics of A20 expression in the focal cerebral is-
chemia/reperfusion for the first time.
To date, A20 mRNA and protein have been detected in
the heart, lung, liver, kidney, and other tissues and organs;
however, its role in the bran is poorly understood. Al-
though some studies [35, 36] found that A20 expression
was upregulated in the rat brain after cerebral ischemia,
suggesting that A20 may be involved in the injury mech-
anism, there was still no accurate description of the dy-
namic expression of A20. The current study revealed that
there was little expression of A20 in the brain tissue of the
sham group rats, suggesting that A20 may not be
expressed in this tissue under normal physiological condi-
tions. A20 mRNA and protein expression was induced
rapidly by focal cerebral ischemia/reperfusion. The peak
expression occurred 24 h after reperfusion, which was
followed by a rapid drop; expression was restored to nor-
mal 72 h after reperfusion. It is unlikely that the upregula-
tion of A20 in this manner would be timely enough and
sufficient to inhibit inflammatory injury, the climax of
which occurred just 24 h after focal cerebral ischemia/re-
perfusion. Several studies [29–33] have also confirmed this
finding, while revealing the effects of A20 on depressing
acute inflammation in the heart, liver, kidney, and other
organs insulted by ischemia. This may be due to delayed
inhibition of the negative feedback for the NF-kB signaling
pathway, which led to an excessive and inappropriate
inflammatory reaction in response to cerebral ischemia/
reperfusion [75]. Therefore, this process needs to be con-
trolled strictly. Furthermore, it is possible that improving
the reaction rate of upregulating A20 and increasing A20
expression is a potential anti-inflammatory strategy. In
particular, it is worth noting that the spatial distribution of
A20 protein in the brain has not been directly exhibited
by other study so far.
Pranski et al. [76] detected A20 mRNA but not protein
expression in the frontal cortex, striatum, hippocampus,
and brain stem of the normal human brain. They specu-
lated that, under normal physiological conditions, only
very low levels of A20 protein synthesis occurs, whereas
upregulation occurs under certain pathological condi-
tions, consistent with the current study. In addition, they
hypothesized that neurons may be the main cell type
that expresses A20 based on the indirect evidence that
some components of the A20 ubiquitin editing enzyme
complex, such as RNF11 (RING finger protein 11),
TAXIBP1 (Tax1 binding protein 1), and Itch, are mainly
expressed in neurons. In the current study, A20 expres-
sion was detected directly in the cytoplasm of rat neu-
rons in the ischemia/reperfusion cortex for the first
time. These spatial distribution characteristics suggest
that neurons may play an important role in the mechan-
ism by which A20 regulates inflammation in the brain.
Although it is unclear why A20 is not upregulated in as-
trocytes and microglial cells, it is possible that there is
no need for A20 in these cells since they are executors
of the inflammatory response.
Studies investigating whether A20 exerts protective ef-
fects in the brain are contradictory. Some functional de-
pletion studies found that CNS-specific A20 knockout
mice exhibited activated astrocytes and microglia, in-
creased inflammatory factor expression in the brain [37],
and developed an aggravated form of autoimmune en-
cephalomyelitis [38]. However, CNS-specific A20 KO
failed to improve neurological outcome in a mouse
MCAO model [35]. In contrast, a gain-of-function study
demonstrated that overexpressing A20 in neurons sig-
nificantly reduced hippocampal neuron apoptosis in a
rat MCAO model [39]. The current study revealed that
A20 overexpression could significantly inhibit neural
function damage and reduce the volume of cerebral in-
farction after focal cerebral ischemia/reperfusion in SD
rats after infection with lentivirus expressing the A20
gene. However, A20 silencing exerted the opposite ef-
fects. These results from two sides of A20 overexpres-
sion and silencing, respectively, indicated that A20
played a protective role at the early stage of ischemia/re-
perfusion in the brain, which suggests that altered A20
expression may help reduce brain injury. To further ex-
plain why neuronal A20 upregulation reduced focal
cerebral ischemia/reperfusion-induced inflammatory in-
jury, correlation analysis revealed that the number of
A20-expressing neurons in the ischemia/reperfusion cor-
tex was significantly positively correlated with neuro-
logical function score but negatively correlated with the
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cerebral infarction volume, glial cell activation, and pro-
inflammatory cytokine content in the brain. This sug-
gests that an increased number of A20-expressing neu-
rons could alleviate inflammatory injury and suppress
the glial cell inflammatory response. Therefore, these re-
sults suggest that neurons play an important role in
regulating neuroinflammation by interaction with glial
cells in response to inflammation. As such, upregulating
neuronal A20 expression could be an important thera-
peutic strategy to reduce the inflammatory injury in the
deficiency of endogenous A20 expression.
EA is an effective clinical treatment for ischemic stroke
and inflammation-related diseases. Our previous study
[51] demonstrated that EA could significantly inhibit early
activation of the NF-kB signaling pathway after cerebral
ischemia/reperfusion and reduce the subsequent inflam-
matory damage; however, the specific regulatory mechan-
ism was not identified. In the current study, we not only
confirmed the therapeutic effects of EA but also demon-
strated that administration of EA beginning 2 h after cere-
bral ischemia could significantly increase A20 mRNA and
protein levels in the brain. The A20 mRNA expression
peaked earlier, and the mRNA and protein expression was
prolonged compared with non-EA rats that underwent
simple ischemia/reperfusion. More specifically, EA in-
creased the number of neurons expressing A20 in the
focal cerebral ischemia/reperfusion cortex. Taken together,
these data suggest that EA could significantly change the
temporal and spatial distribution of A20 in the cerebral is-
chemia/reperfusion area and confirmed that EA is an ef-
fective method to rapidly upregulate A20 expression.
Furthermore, A20 silencing revealed that effects of EA on
inhibiting the production of TNF-α and IL-1β, activating
astrocytes and microglia, infarction formation, and im-
proving neurological outcome were inhibited by blocking
the expression of A20. Thus, A20 is an important regula-
tory target for EA for alleviating inflammatory injury after
cerebral ischemia/reperfusion.
Moreover, the current study demonstrated that EA
inhibited the phosphorylation of IKKβ and IkBα by in-
creasing A20 expression. This reduced the nuclear trans-
location of NF-kB p65 and thereby blocked activation of
the NF-kB signaling pathway. Accordingly, A20 silencing
weakened the inhibitory effects of EA on NF-kB signal-
ing. These results revealed that A20 was the key regula-
tory protein for EA to significantly inhibit the activation
of NF-kB signaling. Since A20 expression was mainly
upregulated in cortical neurons in the ischemic/reperfu-
sion area and there was a close relationship between
A20 and NF-kB signaling, this suggests that A20-
expresssing neurons may be the main target through
which EA inhibits the inflammatory response after acute
cerebral ischemia by regulating the neuronal NF-kB sig-
naling pathway.
The NF-kB signaling pathway is strongly activated in
ischemic brain tissue, including neurons and glial cells.
Generally, activation of the NF-kB signaling pathway in
microglia and astrocytes promotes the formation of in-
flammatory lesion in the CNS [77–80]. However, it is
controversial whether the activation of NF-kB signaling
pathway in neurons exerts beneficial or detrimental im-
pacts on the neuronal apoptosis [81, 82]. The current re-
sults suggested that at early stage of focal cerebral
ischemia/reperfusion, the activation of NF-kB signaling
pathway in neurons was largely inhibited by the upregu-
lation of neuronal A20 expression that resulted in the
transcription of some pro-inflammatory genes such as
TNF-α and IL-1β which were consequently limited. Be-
cause of the large number of neurons, inhibiting the
production of TNF-α and IL-1β from neurons could ef-
fectively reduce their content in the brain tissue, which
decreased the amplification effects of positive feedback
mediated by NF-kB signaling pathway and thereby de-
pressed the activation of glial cells. Finally, the global
NF-kB signaling pathway was suppressed in the cerebral
ischemia/reperfusion area. Therefore, suppressing NF-kB
signaling in neurons at the early stage of cerebral ische-
mia/reperfusion could prevent amplification of the in-
flammatory cascade and promote neuroprotection. In
addition, activation of NF-kB subunits also affected
neuronal survival after cerebral ischemia. Herrmann et
al. [83] found that mice lacking neuronal IKKβ, which is
the upstream kinase in the classical NF-kB signaling
pathway, exhibited significantly reduced neuronal injury
after cerebral ischemia/reperfusion. Multiple studies [5,
8, 84] also demonstrated that the nuclear translocation
of NF-kB p65 played a central role in neuronal cell death
after cerebral ischemia. Other reports demonstrated that
there was a trend toward increased p65 and decreased c-
Rel expression in the ischemic brain tissue of MCAO
mice and oxygen glucose deprived neurons [5, 85]. The
authors proposed that this is a key mechanism in ische-
mic brain injury. However, the current study revealed
that upregulated neuronal A20 expression was likely the
key mechanism by which early EA treatment inhibits
IKKβ phosphorylation and reduces the neuronal nuclear
translocation of p65 to prevent NF-kB signaling-induced
inflammatory injury.
Conclusions
In summary, the current results suggest that ischemia/
reperfusion cortical neurons are the main cell types that
express A20 and that there is a correlation between
neuronal A20 expression and the neuroprotective ef-
fects. EA could upregulate neuronal A20 expression,
which is essential for the anti-inflammatory effects of
EA by suppressing neuronal NF-kB signaling in the
brain of MCAO rats.
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